OMIX010789

1Summary
Title CD8+ TILs in necrotic tumor areas after neoadjuvant immunotherapy predicts recurrence and survival in non-small-cell lung cancer
Description This project aims to identify novel prognostic biomarkers for non-small-cell lung cancer (NSCLC) patients who received neoadjuvant immunotherapy. A total of 229 tumor samples were collected from three medical centers, following treatment with PD-1 blockade combined with chemotherapy. The study discovered that CD8+ tumor-infiltrating lymphocytes in necrotic tumor areas (nTILs) are a strong predictor of event-free survival (EFS). CD8+ nTIL density demonstrated superior prognostic value compared to traditional pathological and radiological assessments. This project provides new insights into immune responses after neoadjuvant immunotherapy and offers potential clinical markers to guide treatment decisions in NSCLC.
Organism Homo sapiens
Data Type Clinical Research data
Data Accessibility Controlled-access
BioProject PRJCA042247
Release Date 2025-11-04
Submitter Hezhe Lu (Hezhe@ioz.ac.cn)
Organization Institute of Zoology, Chinese Academy of Sciences (CAS)
Submission Date 2025-06-27
2Files & Download

HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).

File ID File Title Number/Samples File Type File Size File Suffix Download
OMIX010789-01 supplemental data 1 Clinical Research data 59.5 KB xlsx Controlled

View All Released Data of OMIX